PAR FDA hands Paradigm Biopharma guidance to re-jig phase 3 osteo trial – or is it a delay? Paradigm has confirmed it will use a twice weekly dosage of 2mg/kg injectable pentosan polysulfate sodium in its Phase 3 trial. Jonathon Davidson 4 days ago ASX News Healthcare Biotechnology
Pacific Smiles receives new takeover offer, boosting valuation of shares by 50 cents each Pacific Smiles Group Ltd has received an off-market takeover offer from Beam Dental Bidco Pty Ltd, which follows a previous offer in December Caroline Smith 5 days ago ASX News Healthcare
CU6 Clarity progresses SECuRE trial with positive safety results Clarity Pharmaceuticals Ltd has reported strong results from Cohort 4 of the SECuRE trial examining a treatment for prostate cancer Caroline Smith 12 Sep 2024 12:13 (AEST) ASX News Healthcare
DXB Dimerix begins recruiting young kidney disease patients in Mexico for Phase 3 Dimerix Limited (ASX:DXB) has confirmed it's begun recruiting adolescent kidney disease patients in Mexico, now that its first Phase 3 clinical trial location has been selected. Jonathon Davidson 12 Sep 2024 10:03 (AEST) ASX News Healthcare Biotechnology
PIQ Proteomics ends deal with Sonic Healthcare for US commercialisation of kidney disease test Proteomics International Laboratories Ltd has ended its licencing agreement with Sonic Healthcare USA in relation to PromarkerD. Caroline Smith 11 Sep 2024 12:31 (AEST) ASX News Healthcare Technology Scientific & Technical Instruments
CBL Control Bionics expands into UK and Irish markets with NeuroNode device An agreement between Control Bionics Ltd and Smart Box Ltd will see the latter become exclusive distributor of the NeuroNode wireless device. Caroline Smith 09 Sep 2024 12:12 (AEST) ASX News Healthcare Technology Medical Devices
BIT HotCopper users blunt as Biotron sinks -35%; long-awaited COVID drug results same as placebo Biotron (ASX:BIT) has angered shareholders on HotCopper on Friday as the results of its latest COVID-facing trial come up dusty. Jonathon Davidson 06 Sep 2024 13:04 (AEST) ASX News Healthcare Biotechnology
OCC Orthocell kicks off collagen-based dental bone repair product sales in Canada; eyeing next stop Brazil Orthocell (ASX:OCC) has confirmed its sold its first units of collagen-based bone repair product Striate+ in Canada through distro partner BioHorizons. Jonathon Davidson 06 Sep 2024 10:15 (AEST) ASX News Healthcare Biotechnology
COV CLEO Diagnostics kicks off ovarian cancer-detecting blood test trials in USA Cleo Diagnostics (ASX:COV) has revealed it's kicked off US-based trials sussing the reliability of its blood tests designed to detect ovarian cancer. Jonathon Davidson 06 Sep 2024 09:22 (AEST) ASX News Healthcare
EBR EBR Systems' heart pacing device on-target to reach the US market EBR Systems Ltd has reached a crucial stage in its efforts to commercialise the WiSE® CRT System for US markets. Caroline Smith 04 Sep 2024 15:26 (AEST) ASX News Healthcare Medical Devices
EIQ Echo IQ tests show heart failure can be detected in 86% of cases with AI Echo IQ Ltd has successfully completed two clinical tests showing the viability of applying AI to the detection of heart failure. Caroline Smith 03 Sep 2024 12:32 (AEST) ASX News Healthcare Technology Software - Application
EMD Emyria jumps 10% on 'interim' success treating PTSD patients with MDMA Shares in MDMA psychotherapy player Emyria (ASX:EMD) jumped 9.4% to 3.5cps on Monday following reports of 'interim' success treating patients with PTSD. Jonathon Davidson 02 Sep 2024 10:53 (AEST) ASX News Healthcare
IMU Imugene's azer-cel trial sees tumours temporarily disappear in 3 of 10 patients Imugene (ASX:IMU) has announced 3 patients in its latest blood cancer treatment trial using azer-cel have responded well with one showing a complete response for over 100 days. A @complete response’ in this case is a complete disappearance of all tumours. The company is focusing o... Jonathon Davidson 02 Sep 2024 10:14 (AEST) ASX News Healthcare Biotechnology